zonisamide has been researched along with Argininosuccinate Synthase Deficiency Disease in 1 studies
Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shaikh, AY | 1 |
| Muranjan, MN | 1 |
| Gogtay, NJ | 1 |
| Lahiri, KR | 1 |
1 other study available for zonisamide and Argininosuccinate Synthase Deficiency Disease
| Article | Year |
|---|---|
Possible mechanism for zonisamide-induced hyperammonemia in a child with citrullinemia type 1.
Topics: Anticonvulsants; Child; Citrullinemia; Humans; Hyperammonemia; Isoxazoles; Male; Seizures; Zonisamid | 2009 |